ARMP Insider Trading Activity and SEC Form 4 Filings
ARMP insider trading summary
No open-market insider purchases or sales of Armata Pharmaceuticals, Inc. (ARMP) have been reported on SEC Form 4 in the past 12 months.
Latest ARMP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 31, 2022 | Innoviva Strategic Opportunities LLC | Director | Buy | $26.9M (5,385,208 @ $5.00) |
| Mar 31, 2022 | Innoviva, Inc. | Director | Buy | $26.9M (5,385,208 @ $5.00) |
| Feb 9, 2022 | Innoviva, Inc. | Director | Buy | $18.1M (3,614,792 @ $5.00) |
| Feb 9, 2022 | Innoviva Strategic Opportunities LLC | Director | Buy | $18.1M (3,614,792 @ $5.00) |
| Oct 29, 2021 | Innoviva, Inc. | Director | Buy | $4.0M (1,212,122 @ $3.30) |
| Oct 29, 2021 | Innoviva Strategic Opportunities LLC | Director | Buy | $4.0M (1,212,122 @ $3.30) |
| Mar 17, 2021 | Innoviva Strategic Opportunities LLC | Director | Buy | $13.9M (4,285,935 @ $3.25) |
| Mar 17, 2021 | Innoviva, Inc. | Director | Buy | $13.9M (4,285,935 @ $3.25) |
| Jan 26, 2021 | Innoviva Strategic Opportunities LLC | Director | Buy | $6.1M (1,867,912 @ $3.25) |
| Jan 26, 2021 | Innoviva, Inc. | Director | Buy | $6.1M (1,867,912 @ $3.25) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.